n-methyladenosine has been researched along with Diabetes Mellitus, Type 2 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, SM; Ma, LL; Wang, BH; Xie, W; Xu, YQ | 1 |
| Avruch, J; Dai, N; Ji, F; Regué, L; Wang, H; Zhao, L | 1 |
| Huang, JT; Huang, W; Liu, SM; Qin, S; Sergi, C; Shen, F; Yang, Y; Yuan, BF | 1 |
| Dahl, JA; Klungland, A | 1 |
| Chen, J; Feng, YQ; Huang, JT; Huang, W; Jia, GF; Liu, SM; Shen, F; Wu, K; Xiong, J; Yang, Y; Yuan, BF | 1 |
| Guo, X; Ji, S; Ji, X; Wei, W | 1 |
2 review(s) available for n-methyladenosine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Dynamic RNA modifications in disease.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Diabetes Mellitus, Type 2; Dioxygenases; Humans; Membrane Proteins; Methyltransferases; Mutation; Obesity; Proteins; RNA, Messenger | 2014 |
Regulatory Role of N
Topics: Adenosine; Animals; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Methylation; Neoplasms; Obesity; RNA Processing, Post-Transcriptional; RNA, Neoplasm | 2017 |
4 other study(ies) available for n-methyladenosine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Topics: Adenosine; Animals; Dependovirus; Diabetes Mellitus, Type 2; Disease Models, Animal; Fatty Acid Synthase, Type I; Fatty Acids; Gene Deletion; Glucose; Hepatocytes; Homeostasis; Humans; Insulin Resistance; Liver; Methylation; Methyltransferases; Mice, Inbred C57BL; Mice, Knockout; Obesity; RNA, Messenger | 2019 |
RNA m6A reader IMP2/IGF2BP2 promotes pancreatic β-cell proliferation and insulin secretion by enhancing PDX1 expression.
Topics: Adenosine; Animals; Cell Line; Cell Proliferation; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gene Knockout Techniques; Homeodomain Proteins; Humans; Insulin Secretion; Insulin-Secreting Cells; Insulin, Regular, Human; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Promoter Regions, Genetic; Rats; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Trans-Activators; Transfection | 2021 |
Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Blood Glucose; Diabetes Mellitus, Type 2; Diacylglycerol O-Acyltransferase; Female; Forkhead Box Protein O1; Gene Knockdown Techniques; Glucose-6-Phosphatase; Hep G2 Cells; Humans; Male; Methyltransferases; Middle Aged; RNA, Messenger; Up-Regulation | 2019 |
Decreased N(6)-methyladenosine in peripheral blood RNA from diabetic patients is associated with FTO expression rather than ALKBH5.
Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Biomarkers; Diabetes Mellitus, Type 2; Dioxygenases; Epigenesis, Genetic; Female; Humans; Male; Membrane Proteins; Proteins; Rats | 2015 |